SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-024871
Filing Date
2011-03-11
Accepted
2011-03-11 17:19:33
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K g26446e10vk.htm 10-K 1088474
2 EX-10.11 g26446exv10w11.htm EX-10.11 21955
3 EX-10.12 g26446exv10w12.htm EX-10.12 22033
4 EX-10.13 g26446exv10w13.htm EX-10.13 21968
5 EX-10.15 g26446exv10w15.htm EX-10.15 22893
6 EX-10.26 g26446exv10w26.htm EX-10.26 21891
7 EX-23.1 g26446exv23w1.htm EX-23.1 3631
8 EX-31.1 g26446exv31w1.htm EX-31.1 10308
9 EX-31.2 g26446exv31w2.htm EX-31.2 10344
10 EX-32.1 g26446exv32w1.htm EX-32.1 4394
11 GRAPHIC g26446g2644601.gif GRAPHIC 7951
  Complete submission text file 0000950123-11-024871.txt   1239973
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 11683157
SIC: 2834 Pharmaceutical Preparations